COVID-19 case severity: How genetic differences leave immune cells at a disadvantage
New LJI research shows how a range of critical immune cells respond to SARS-CoV-2
Six LJI scientists named “Highly Cited Researchers”
The international recognition reflects how LJI research is valued by scientific peers
Erica Ollmann Saphire receives $2.6 million grant to collaborate on pan-coronavirus vaccine
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus family
Beauty in science
Mexican sculptor assembles an emotional tribute to COVID-19 research
Lungs of COVID-19 survivors teem with virus-fighting ‘memory’ cells
Even elderly survivors show a strong, persistent immune memory
From Alpha to Epsilon: Consortium study illuminates surfaces of Spike most resistant to antibody escape
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
Moderna COVID-19 vaccine spurs lasting immune response
Immune system memory stays strong 6+ months post-vaccination, similar to responses in recovered COVID-19 patients
What you need to know about variants, vaccines, and breakthrough COVID cases
Can we stretch existing Covid vaccines to inoculate more people? Experts are divided
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
In-Depth: La Jolla Institute takes comprehensive look at COVID-19 immunity
Study compares four vaccines and natural immunity